Recombinant SARS-CoV-2 Nucleocapsid anticorps

N° du produit ABIN6973311

Cet anticorps anti-SARS-CoV-2 Nucleocapsid est un anticorps Human Monoclonal détectant SARS-CoV-2 Nucleocapsid dans ELISA. Adapté pour SARS Coronavirus-2 (SARS-CoV-2).

Aperçu rapide pour Recombinant SARS-CoV-2 Nucleocapsid anticorps (ABIN6973311)

Antigène: SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Type d'anticorp: Recombinant Antibody

Reactivité: SARS Coronavirus-2 (SARS-CoV-2)

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp SARS-CoV-2 Nucleocapsid est non-conjugé

Application: ELISA

Clone: CR3018

Détail du produit anti-SARS-CoV-2 Nucleocapsid anticorps

Specificité: Nucleoprotein of SARS-CoV-2 (aa 11-19) which corresponds to the sequence RSAPRITFG of the N protein of SARS-CoV

Immunogène: Recombinant antibody from a phage display library,Generated by sequencing peripheral blood lymphocytes of a patient exposed to the SARS-CoV

Isotype: IgG, kappa

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Buffer: Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free

Agent conservateur: Without preservative

Stock: 4 °C

Stockage commentaire: Stable at +2-8°C for 12 months. For longer storage freeze aliquots.

Détails sur SARS-CoV-2 Nucleocapsid

Antigène: SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Autre désignation: SARS-CoV-2 Nucleoprotein

Classe de substances: Viral Protein

Sujet: Nucleoprotein / SARS-CoV nucleoprotein / Nucleocapsid protein